Menopause

More Benefits, Less Confidence: Maven Clinic’s Fifth Annual Report Examines the Impact of Fragmented Women’s and Family Health Benefits

New research shows how access barriers, rising costs, GLP-1 demand, and AI-driven care—not just more coverage—will define the next generation...

Kindbody Unveils Next-Generation Fertility Platform to Improve Outcomes, Accelerate Affordability and Intelligence in Reproductive Care

Kindbody's Enhanced Platform Integrates AI, Clinical Innovation, and Whole‑Family Support to Improve Outcomes, Reduce Costs, and Elevate Patient ExperienceNEW YORK,...

Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women

Pre-Fulfillment Prescribing Now Available in All 50 States, Supporting National LaunchDeveloped and evaluated specifically for women, DARE to PLAY™ Sildenafil...

Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women

Pre-Fulfillment Prescribing Now Available in All 50 States, Supporting National LaunchDeveloped and evaluated specifically for women, DARE to PLAY™ Sildenafil...

WIN Expanded Preconception Program: AI-Driven, Data-Informed, and Clinical-Led Personalized Care for Every Stage of the Journey

Companies integrating the program achieve improved outcomes, reduced high-cost claims, and greater employee satisfaction GREENWICH, Conn., Jan. 21, 2026 /PRNewswire/...

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz’s Team and an “Evidence Sprint 2026” Focused on Grants, Research and Clinical Evidence

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on...

error: Content is protected !!